-+ 0.00%
-+ 0.00%
-+ 0.00%

What to Expect From UnitedHealth’s Next Quarterly Earnings Report

Barchart·09/29/2026 06:21:56
Listen to the news

UnitedHealth Group Incorporated (UNH), headquartered in Minnetonka, Minnesota, owns and manages organized health systems. With a market cap of $338 billion, the company provides employers products and resources to plan and administer employee benefit programs serving customers worldwide. The health insurance giant is expected to announce its fiscal third-quarter earnings for 2026 before the market opens on Tuesday, Oct. 13.

Ahead of the event, analysts expect UnitedHealth to report a profit of $4.12 per share on a diluted basis, up 41.1% from $2.92 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports. 

For the full year, analysts expect UnitedHealth to report EPS of $19.85, up 21.4% from $16.35 in fiscal 2025. Its EPS is expected to rise 13.6% year over year to $22.54 in fiscal 2027. 

www.barchart.com

UNH stock has underperformed the S&P 500 Index’s ($SPX) 15.7% gains over the past 52 weeks, with shares up 9.8% during this period. Similarly, it underperformed the State Street Health Care Select Sector SPDR ETF’s (XLV) 26.4% gains over the same time frame.

www.barchart.com

UNH has faced persistent stock pressure over the past year as managed-care investors contend with a slower-than-expected fundamental recovery. Stock sentiment has been weighed down by elevated medical care costs, out-of-network arbitration expenses, and broader regulatory headwinds, which pushed UNH shares below $400. Although expanding commercial fee-based membership and stronger momentum in technology units like Optum Insight provided steady support, these tailwinds were tempered by operational friction and margin pressure in Optum Health, softening Optum Rx trends, and declines in risk-based membership. Consequently, despite serving 48.5 million members, these uneven segment results and ongoing commercial challenges have reminded investors that UNH's operational rebound remains an incremental process. 

Analysts’ consensus opinion on UNH stock is bullish, with a “Strong Buy” rating overall. Out of 26 analysts covering the stock, 18 advise a “Strong Buy” rating, three suggest a “Moderate Buy,” and five give a “Hold.” UNH’s average analyst price target is $478.50, indicating a notable potential upside of 26.6% from the current levels.


On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.